Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

9.05
+0.39004.50%
Pre-market: 8.80-0.2500-2.76%04:09 EDT
Volume:721.10K
Turnover:6.49M
Market Cap:494.10M
PE:-5.49
High:9.24
Open:8.61
Low:8.51
Close:8.66
Loading ...
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Correspondence

Form CORRESP - Correspondence
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities